ArticleFrontiers in immunology2018

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.

Hiroshi Koga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.